Vertex Pharmaceuticals, Inc. - VRTX - stock price prediction, stock price target, analyst ratings from 34 analysts

Vertex Pharmaceuticals, Inc. has a share price target of US$ 500, revenue growth forecast of 8.3%, and profit growth estimate of 825.4% for FY25, based on top 34 analyst calls.